These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 684075)

  • 61. 3H-5-hydroxytryptamine accumulation by rat brain synaptic vesicles in a membrane-impermeant medium, and selective reduction by 5,7-dihydroxytryptamine.
    Ruth JA; Cuizon JV; Park SH; Ullman EA; Wilson WR
    Life Sci; 1986 Mar; 38(13):1193-201. PubMed ID: 3959750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Developmental variations of brain serotonin, tryptophan, 5-hydroxyindole acetic acid, and noradrenaline and dopamine content in two inbred strains of mice.
    Daszuta A; Barrit MC; Faudon M
    Dev Neurosci; 1982; 5(2-3):130-42. PubMed ID: 6181954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of cerebral 5-hydroxytryptamine for convulsive threshold and anticonvulsant effect of acetazolamide in rats.
    Przegaliński E
    Arch Immunol Ther Exp (Warsz); 1976; 24(6):821-7. PubMed ID: 138403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of monoamine neurotoxins on peptides in the rat spinal cord.
    Gilbert RF; Emson PC; Hunt SP; Bennett GW; Marsden CA; Sandberg BE; Steinbusch HW; Verhofstad AA
    Neuroscience; 1982 Jan; 7(1):69-87. PubMed ID: 6176903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regeneration of normal terminal innervation patterns by central noradrenergic neurons after 5,7-dihydroxytryptamine-induced axotomy in the adult rat.
    Björklund A; Lindvall O
    Brain Res; 1979 Aug; 171(2):271-93. PubMed ID: 466444
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
    Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
    Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dihydroxytryptamines as tools to study the neurobiology of serotonin.
    Baumgarten HG; Klemm HP; Sievers J; Schlossberger HG
    Brain Res Bull; 1982; 9(1-6):131-50. PubMed ID: 7172024
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vivo labeling of serotonin-containing neurons by 5,7-dihydroxytryptamine in Aplysia.
    Jahan-Parwar B; Rozsa KS; Salanki J; Evans ML; Carpenter DO
    Brain Res; 1987 Nov; 426(1):173-8. PubMed ID: 3690314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
    Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
    Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.
    Heal DJ; Philpot J; Molyneux SG; Metz A
    Neuropharmacology; 1985 Dec; 24(12):1201-5. PubMed ID: 4094656
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of serotoninergic and adrenergic mechanisms in the action of prominal.
    Nowakowska E; Godlewski J
    Acta Physiol Pol; 1979; 30(5-6):581-7. PubMed ID: 93847
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
    Pranzatelli MR; Dollison AM; Hlibczuk V
    Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH
    Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
    Enters EK; Specht SM; Spear LP
    Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of neonatal 5,7-dihydroxytryptamine treatment on the development of serotonin neurons and their transmitter metabolism.
    Ponzio F; Jonsson G
    Dev Neurosci; 1978; 1(2):80-9. PubMed ID: 755684
    [No Abstract]   [Full Text] [Related]  

  • 77. Biochemical evidence for alteration of neostriatal dopaminergic function by 5,7-dihydroxytryptamine.
    Liston DR; Franz DN; Gibb JW
    J Neurochem; 1982 May; 38(5):1329-35. PubMed ID: 6121011
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

  • 79. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

  • 80. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.